Independent association of anti-beta(2)-glycoprotein I antibodies with macrovascular disease and mortality in scleroderma patients.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Arthritis & Rheumatism

• Publication date

  2009-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/art.24684PMID 19644882PMCID PMC2746063
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Vascular Disease in Scleroderma

  2009cited by this paper
• IgA antiphospholipid antibodies are an independent risk factor for thromboses

  2008cited by this paper
• Macrovascular disease and atherosclerosis in SSc.

  2008cited by this paper
• Autoantibodies to the Atheroma Component Beta2-Glycoprotein I and Risk of Symptomatic Peripheral Artery Disease

  2007cited by this paper
• Anticardiolipin and anti‐β2 glycoprotein I antibodies and lupus‐like anticoagulant: prevalence and significance in systemic sclerosis

  2007cited by this paper
• Beta2-glycoprotein I binds thrombin via exosite I and exosite II: anti-beta2-glycoprotein I antibodies potentiate the inhibitory effect of beta2-glycoprotein I on thrombin-mediated factor XIa generation.

  2007cited by this paper
• Anti‐beta 2 glycoprotein I antibodies and the risk of myocardial infarction in young premenopausal women

  2007cited by this paper
• Systemic sclerosis: a prototypic multisystem fibrotic disorder.

  2007cited by this paper
• Hand vascular involvement assessed by magnetic resonance angiography in systemic sclerosis.

  2007cited by this paper
• Angiographically proven coronary artery disease in scleroderma.

  2006cited by this paper
• Anti-beta2-glycoprotein I: prevalence, clinical correlations, and importance of persistent positivity in patients with antiphospholipid syndrome and systemic lupus erythematosus.

  2006cited by this paper
• Transforming growth factor-beta regulation of immune responses.

  2006cited by this paper
• Prevalence of antiphospholipid antibodies in systemic sclerosis and association with primitive pulmonary arterial hypertension and endothelial injury.

  2005cited by this paper
• Annexin A2 mediates endothelial cell activation by antiphospholipid/anti-beta2 glycoprotein I antibodies.

  2005cited by this paper
• Phosphatidylserine IgG and beta-2-glycoprotein I IgA antibodies may be a risk factor for ischaemic stroke.

  2005cited by this paper
• The prevalence and clinical significance of antiphospholipid antibodies in the patients with systemic sclerosis--preliminary report.

  2005cited by this paper
• Antiphospholipid antibodies in patients with scleroderma: prevalence and clinical significance

  2005cited by this paper
• Anti-beta 2-glycoprotein I and antiphosphatidylserine antibodies are predictors of arterial thrombosis in patients with antiphospholipid syndrome.

  2004cited by this paper
• Antiphospholipid antibodies in acute coronary syndrome

  2003cited by this paper
• More on anticardiolipin and anti-beta2 glycoprotein I in systemic sclerosis.

  2003cited by this paper
• Bacterial induction of autoantibodies to beta2-glycoprotein-I accounts for the infectious etiology of antiphospholipid syndrome.

  2002cited by this paper
• Heavy cigarette smoking and RA

  2002cited by this paper
• Criteria for the classification of early systemic sclerosis.

  2001cited by this paper
• Antiphospholipid antibody system in systemic sclerosis.

  2001cited by this paper
• Clinical features of systemic sclerosis.

  2001cited by this paper
• The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.

  2001cited by this paper
• Catheter angiography and angioplasty in patients with scleroderma.

  2001cited by this paper
• T cells that are autoreactive to beta2-glycoprotein I in patients with antiphospholipid syndrome and healthy individuals.

  2000cited by this paper
• Analysis of T cell responses to the beta 2-glycoprotein I-derived peptide library in patients with anti-beta 2-glycoprotein I antibody-associated autoimmunity.

  2000cited by this paper
• Analysis of T cell responses to the β2-glycoprotein I-derived peptide library in patients with anti-β2-glycoprotein I antibody-associated autoimmunity

  2000cited by this paper
• The frequency and significance of anticardiolipin antibodies in scleroderma.

  2000cited by this paper
• Anti-annexin V antibodies and digital ischemia in patients with scleroderma.

  1999cited by this paper
• Beta2-glycoprotein I (beta2-GPI) mRNA is expressed by several cell types involved in anti-phospholipid syndrome-related tissue damage.

  1999cited by this paper
• Antiphospholipid (Hughes') syndrome in African-Americans: IgA aCL and aβ2 glycoprotein-I is the most frequent isotype

  1999cited by this paper
• International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop.

  1999cited by this paper
• β2‐glycoprotein I (β2‐GPI) mRNA is expressed by several cell types involved in anti‐phospholipid syndrome‐related tissue damage

  1999cited by this paper
• Beta2-glycoprotein I is necessary to inhibit protein C activity by monoclonal anticardiolipin antibodies.

  1999cited by this paper
• A disease severity scale for systemic sclerosis: development and testing.

  1999cited by this paper
• Antiendothelial cell antibodies in scleroderma correlate with severe digital ischemia and pulmonary arterial hypertension.

  1998cited by this paper
• Comparison of Doppler echocardiography and right heart catheterization to assess pulmonary hypertension in systemic sclerosis.

  1997cited by this paper
• Involvement of β2‐glycoprotein I and anticardiolipin antibodies in oxidatively modified low‐density lipoprotein uptake by macrophages

  1997cited by this paper
• Measurement of anticardiolipin antibodies by ELISA using β2‐glycoprotein I (β2‐GPI) in systemic sclerosis

  1996cited by this paper
• The prevalence and clinical associations of anticardiolipin antibodies in a large inception cohort of patients with connective tissue diseases.

  1996cited by this paper
• Measurement of anticardiolipin antibodies by ELISA using beta 2-glycoprotein I (beta 2-GPI) in systemic sclerosis.

  1996cited by this paper
• Limited scleroderma is associated with increased prevalence of macrovascular disease.

  1995cited by this paper
• Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis.

  1995cited by this paper
• Anticardiolipin antibodies recognize beta 2-glycoprotein I structure altered by interacting with an oxygen modified solid phase surface

  1994cited by this paper
• Anticardiolipin, anticentromere and anti-Scl-70 antibodies in patients with systemic sclerosis and severe digital ischaemia.

  1994cited by this paper
• Lung function testing: selection of reference values and interpretative strategies.

  1992cited by this paper
• Anticentromere antibody as a predictor of digital ischemic loss in patients with systemic sclerosis.

  1992cited by this paper
• Lung function testing: selection of reference values and interpretative strategies. American Thoracic Society.

  1991cited by this paper
• Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man.

  1989cited by this paper
• Clinical correlations and prognosis based on serum autoantibodies in patients with systemic sclerosis.

  1988cited by this paper
• The anticardiolipin syndrome.

  1985cited by this paper
• The anticardiolipin syndrome.

  1985cited by this paper
• Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee.

  1980cited by this paper
• Preliminary criteria for the classification of systemic sclerosis (scleroderma).

  1980cited by this paper

• Cardiovascular and venous thromboembolic events in systemic sclerosis: epidemiological analysis of the Clinical Practice Research Datalink.

  2025cites this paper
• Serum Biomarkers in Connective Tissue Disease-Associated Pulmonary Arterial Hypertension

  2023cites this paper
• 失敗から学ぶ研究論：論文演題名編

  2023cites this paper
• Endothelial Dysfunction in Systemic Lupus Erythematosus and Systemic Sclerosis: A Common Trigger for Different Microvascular Diseases

  2022cites this paper
• Antiphospholipid Antibodies in Inflammatory and Autoimmune Rheumatic and Musculoskeletal Diseases Beyond Lupus: A Systematic Review of the Available Evidence

  2021cites this paper
• Association between systemic sclerosis and peripheral arterial disease: a nationwide observation retrospective claim records cohort study in Taiwan

  2021cites this paper
• Anti-phospholipid syndrome leading to digital ischaemia and rare organ complications in systemic sclerosis and related disorders

  2020cites this paper
• The Weight of IgA Anti-β2glycoprotein I in the Antiphospholipid Syndrome Pathogenesis: Closing the Gap of Seronegative Antiphospholipid Syndrome

  2020cites this paper
• Systemic sclerosis and risk of cardiovascular disease

  2020cites this paper
• Systemic sclerosis is an independent risk factor for ischemic heart disease, especially in patients carrying certain antiphospholipid antibodies: A large cross-sectional study.

  2020cites this paper
• Nonthrombotic proliferative vasculopathy associated with antiphospholipid antibodies: A case report and literature review

  2019cites this paper
• A propos de l'atteinte macrovasculaire de la Sclérodermie systémique : revue de la littérature et étude SCLEROMACROVASC

  2019influential citation
• Lung Disease in Antiphospholipid Syndrome

  2019cites this paper
• Autoimmune connective tissue diseases and pregnancy.

  2019cites this paper
• Association of antiphospholipid antibodies with active digital ulceration in systemic sclerosis

  2019cites this paper
• [Systemic sclerosis and macrovascular involvement: Status of the issue in 2019].

  2019cites this paper
• Clinical significance of autoantibodies in dermatomyositis and systemic sclerosis.

  2018cites this paper
• Prevalence of auto-antibodies associated to pulmonary arterial hypertension in scleroderma - A review.

  2018cites this paper
• Prevalence and Clinical Associations of Antiphospholipid Antibodies in Systemic Sclerosis: New Data From a French Cross-Sectional Study, Systematic Review, and Meta-Analysis

  2018cites this paper
• Revisión Manejo integral de las pacientes con esclerosis sistémica durante el embarazo

  2018cites this paper
• IgA anti-β2 glycoprotein I antibodies: Experience from a large center.

  2018cites this paper
• Chapter 2 Atherosclerosis and Cardiovascular Risk in Systemic Sclerosis

  2018cites this paper
• Digital Loss (Gangrene, Amputation, Autoamputation)

  2018cites this paper
• Autoimmune Disease in Pregnancy (Content last reviewed: 23rd July 2019)

  2017cites this paper
• Critical Ischemia in Patients with Raynaud’s Phenomenon

  2017cites this paper
• Chapter 13 – Systemic Sclerosis

  2017cites this paper
• Atherosclerosis and Cardiovascular Risk in Systemic Sclerosis

  2017cites this paper
• Clinical relevance of antiphospholipid antibodies in systemic sclerosis: A systematic review and meta-analysis.

  2017cites this paper
• omprehensive Approach to Systemic Sclerosis Patients uring Pregnancy

  2017cites this paper
• Raynaud's phenomenon.

  2016cites this paper
• Differential diagnosis of critical digital ischemia in systemic sclerosis: Report of five cases and review of the literature.

  2016cites this paper
• Anticuerpos antinucleares específicos de la esclerodermia como determinantes del pronóstico y de los diferentes patrones clínicos de la enfermedad

  2016cites this paper
• Systemic sclerosis presenting with severe digital ischemia: A rare case report

  2015cites this paper
• [Large vessels vasculopathy in systemic sclerosis].

  2015cites this paper
• Comprehensive Approach to Systemic Sclerosis Patients During Pregnancy

  2015cites this paper
• Differential assay reactivity of immunglobulin A anti-ß2 glycoprotein I antibodies: implications for the clinical interpretation of antiphospholipid antibody testing.

  2015cites this paper
• Relation of Immunoglobulin A Isotype of Anti-ß 2 Glycoprotein I to Clinical and Laboratory Features of Antiphospholipid Syndrome and Systemic Lupus Erythematosus

  2015cites this paper
• Sensitivity and Specificity of Immunoglobulin A Isotype of Anti-ß 2 Glycoprotein I in Patients with Systemic Lupus Erythematosus and Secondary Antiphospholipid Syndrome

  2015cites this paper
• Association of anti phosphatidyl ethanolamine antibodies and low complement levels in systemic sclerosis patients – results of a cross-sectional study

  2015cites this paper
• Other Secondary Causes

  2015cites this paper
• Large vessels vasculopathy in systemic sclerosis

  2015cites this paper
• Comprehensive approach to systemic sclerosis patients during pregnancy.

  2015cites this paper
• Vasculopatía de grandes vasos en la esclerosis sistémica

  2015cites this paper
• Immunoglobulin G is the only anti-beta-2-glycoprotein I isotype that associates with unprovoked thrombotic events among hospital patients

  2014cites this paper
• Value of Isolated IgA anti-β2GPI Positivity in the Diagnosis of the Antiphospholipid Syndrome

  2014cites this paper
• The association of antiphospholipid antibodies with cardiopulmonary manifestations of systemic sclerosis.

  2014cites this paper
• Is atherosclerosis accelerated in systemic sclerosis? Novel insights

  2014cites this paper
• Value of isolated IgA anti-β2 -glycoprotein I positivity in the diagnosis of the antiphospholipid syndrome.

  2013cites this paper
• Clinical Significance of IgA Anti-Cardiolipin and IgA Anti-β2Glycoprotein I Antibodies

  2013cites this paper
• Associations with Organ Involvement and Autoantibodies in Systemic Sclerosis: Results from the Canadian Scleroderma Research Group (CSRG)

  2013cites this paper
• Autoantibodies in systemic sclerosis.

  2013cites this paper
• Pregnancy issues in scleroderma.

  2012cites this paper
• The Clinical Aspects of Autoantibodies

  2012cites this paper
• Kritische Extremitäten- ischämie bei systemischer Sklerose

  2012cites this paper
• Kritische Extremitätenischämie bei systemischer Sklerose

  2012cites this paper
• IgA antibodies against β2 glycoprotein I in hemodialysis patients are an independent risk factor for mortality.

  2012cites this paper
• Identification and characterization of IgA antibodies against β2‐glycoprotein I in childhood Henoch–Schönlein purpura

  2012cites this paper
• Macrovascular involvement in systemic sclerosis: evidence of correlation with disease activity.

  2012cites this paper
• Pulmonary arterial hypertension in connective tissue

  2012cites this paper
• Ocena częstości występowania i znaczenia klinicznego przeciwciał przeciwfosfolipidowych u chorych na twardzinę układową

  2012cites this paper
• [Critical limb ischemia in systemic sclerosis].

  2012cites this paper
• Pulmonary arterial hypertension in connective tissue diseases.

  2012cites this paper
• Task Force Report on “Non-criteria” Antiphospholipid Antibody Tests

  2012cites this paper
• ' Non-criteria ' aPL tests : report of a task force and preconference workshop at the 13 th International

  2011cites this paper
• Induction of anti‐β2‐glycoprotein I autoantibodies in mice by protein H of Streptococcus pyogenes

  2011cites this paper
• Cardiovascular disease in systemic sclerosis - an emerging association?

  2011cites this paper
• ‘Non-criteria’ aPL tests: report of a task force and preconference workshop at the 13th International Congress on Antiphospholipid Antibodies, Galveston, TX, USA, April 2010

  2011cites this paper
• ‘Criteria’ aPL tests: Report of a Task Force and preconference workshop at the 13th International Congress on Antiphospholipid Antibodies, Galveston, Texas, April 2010

  2011cites this paper
• Esclerodermia (esclerosis sistémica)

  2010cites this paper
• Pulmonary Arterial Hypertension and Lung Transplantation

  2010cites this paper
• IgA Anti-β2-Glycoprotein I Autoantibodies Are Associated with an Increased Risk of Thromboembolic Events in Patients with Systemic Lupus Erythematosus

  2010cites this paper
• Autoantibodies as predictive tools in systemic sclerosis

  2010cites this paper
• Pulmonary arterial hypertension and lung transplantation.

  2010cites this paper
• The burden and measurement of cardiovascular disease in SSc

  2010cites this paper
• Raynaud's phenomenon and digital ischemia: a practical approach to risk stratification, diagnosis and management.

  2010cites this paper
• Digital Ischemic Loss in Systemic Sclerosis

  2010cites this paper
• Vascular Disease in Scleroderma

  2009cites this paper
• Antiphospholipid Antibodies in Inflammatory and Autoimmune Rheumatic and Musculoskeletal Diseases Beyond Lupus: A Systematic Review of the Available Evidence

  year unknowncites this paper